Parsonage-Turner syndrome: A rare case of abacavir hypersensitivity reaction in HIV-infected patients

Journal of Infection

Volumn 57, Issue 1, 2008, Pages 88-90

  Bellagamba, R ^a   Tommasi, C ^a   De Marco, M ^a   Narciso, P ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ATAZANAVIR; DIAMINOCILLIN; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PYRIDOXINE; RITONAVIR; TENOFOVIR; THIAMINE;

ADULT; ANAMNESIS; BLOOD EXAMINATION; BRACHIAL PLEXUS NEUROPATHY; CASE REPORT; CAUCASIAN; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KAPOSI SARCOMA; LETTER; MALE; MUSCLE INJURY; MYALGIA; NEURALGIC AMYOTROPHY; NONHUMAN; PARESTHESIA; PHARMACOGENOMICS; PHARYNGITIS; PHYSICAL EXAMINATION; PHYSIOTHERAPY; SYMPTOM; SYPHILIS; VIRUS MUTATION; VIRUS STRAIN;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRACHIAL PLEXUS NEURITIS; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HIV-1; HUMANS; MALE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 46149105176     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.05.001     Document Type: Letter

References (17)

1. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (January 29, 2008), Department of Health and Human Services p. 1-128
2. Kessler H.A., Johnson J., Follansbee S., Sension M.G., Mildvan D., Sepulveda G.E., et al. Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1. Clin Infect Dis 34 4 (2002) 535-542
3. Chirouze C., Hustache-Mathieu L., Rougeot C., Drobacheff C., Gil H., Faller J.P., et al. Risk factors for Abacavir-induced hypersensibility syndrome in the "real world". Pathol Biol (Paris) 52 (2004) 529-533
4. Waters L.J., Mandalia S., Gazzard B., and Nelson M. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. AIDS 21 (2007) 2533-2534
5. Chui C.K., Brumme Z.L., Brumme C.J., Yip B., Phillips E.J., Montaner J.S., et al. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Clin Infect Dis 44 (2007) 1503-1508
6. Mallal S., Phillips E., Carosi G., Molina J.M., Workman C., Tomazic J., et al., for the PREDICT-1 Study Team. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358 (2008) 568-579
7. Hughes A.R., Mosteller M., Bansal A.T., Davies K., Haneline S.A., Lai E.H., et al., for the CNA30027 Study Team and CNA30032 Study Team. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 5 2 (2004) 203-211
8. Saag M., Balu R., Phillips E., Brachman P., Martorell C., Burman W., et al., for the Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team. High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Infect Dis 46 (2008) 1111-1118
9. Fernández Valdivieso E., Montesinos Sanz S., and Díez Lázaro C. Parsonage-Turner syndrome. Aten Primaria 39 (2007) 622
10. Saleem F., and Mozaffar T. Neuralgic amyotrophy (Parsonage-Turner syndrome): an often misdiagnosed diagnosis. J Pak Med Assoc 49 (1999) 101-103
11. Botella M.S., García M., Cuadrado J.M., and Martín R. Parsonage-Turner syndrome in positive HIV patients. Rev Neurol 25 (1997) 143
12. Louis E., Touzé E., Piketty M.L., Salmon-Céron D., and Zuber M. Bilateral amyotrophic neuralgia (Parsonage Turner syndrome) with HIV seroconversion. Rev Neurol 159 6-7 Pt 1 (2003) 685-687
13. Guihot A., Dupin N., Marcelin A.G., Gorin I., Bedin A.S., Bossi P., et al. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 194 (2006) 1078-1088
14. French M.A., Price P., and Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 18 (2004) 1615-1627
15. Pirmohamed M., Drummonds N.S., Naisbitt D.J., and Park M.K. Drug hypersensitivity reactions in patients with HIV disease. Expert Rev Clin Immunol 3 (2007) 395-410
16. Martin A.M., Nolan D., Gaudieri S., Almeida C.A., Nolan R., James I., et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci U S A 101 (2004) 4180-4185
17. Phillips E.J., Wong G.A., Kaul R., Shahabi K., Nolan D.A., Knowles S.R., et al. Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS 19 (2005) 979-981